Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Revvity, Inc. (RVTY), a provider of life sciences and diagnostics tools, was another detractor for the quarter. Early in the...
— Gary H. Miller
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Revvity Inc.
Revvity ($RVTY) is a specialized life science tools and diagnostic testing company providing research informatics software, preclinical discovery reagents, and clinical diagnostic systems. Madison initiated a...
Revvity successfully restructured post-pandemic by divesting lower-margin assets to build specialized diagnostic and research reagent franchises. The company trades...
More institutional theses from Sycamore Mid Cap Value Equity
The company posted solid earnings driven by robust demand in advanced semiconductor manufacturing and AI applications. Management refinanced its...
The company benefited from a constructive nitrogen pricing backdrop, low customer inventories, and tight global supply. Disruptions in the...
The company reported strong earnings and guidance driven by robust demand from data centers and AI infrastructure. Rising revenues, margins,...